TRIANNI sponsors The Werner Müller Award for Excellence in Immunology

San Francisco, CA, USA. and Berlin, Germany, December 6, 2017 –Trianni, Inc. (“TRIANNI”) announced that it will sponsor the Werner Müller Award, which will be administrated by The German Society for Immunology (DGfi).

The Werner Müller Award will be awarded to postdocs for their achievements in the field of immunology that can be of benefit for the prevention, diagnosis or treatment of diseases of countries of the developing world. Nominations for the award must be submitted by January 31st, 2018. Visit for more details.

The award is named after Werner Müller, a pioneer involved in the development of the first humanized antibody producing mouse strain, along with countless other transgenic mice used all over the world. He is a founding member of the IMGT database and holds the Bill Ford Chair of Cellular Immunology at the university of Manchester UK.


About Trianni, Inc.
Trianni, Inc. is a privately held biotech company specializing in antibody discovery technology. TRIANNI’s lead technology, The Trianni Mouse™, is a powerful, next-generation platform enabling efficient generation of fully-human monoclonal antibodies. TRIANNI’s transgenic platform leverages a novel approach to design made possible by advances in DNA synthesis and genomic modification technology making it a best-in-class therapeutic antibody discovery platform.  The company is headquartered in San Francisco, CA. Additional information about TRIANNI is available through its corporate website,

About the German Society for Immunology (DGfI)
The DGfI was founded in 1967 and has more than 2,300 members studying or working in basic and/or clinical immunology. The scientific activities of members are organized in 13 research focus groups. The DGfI hosts annual meetings and smaller bilateral meetings together with non-European societies in order to initiate and promote joint research projects. Through ‘DGfI Academy of Immunology’ they offer structured education in immunology via three modules of training courses. Their public outreach program ‘Immunology for Everyone’ develops information material and organize events for the interested public, schools and patients. For more information please see and resp.